Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

0
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Category

Show more Refine

For: Minihan B, McAuliffe E, Powell J, Wong SL, Wilkie K, Murphy C, Maher A, Power L, O'Connell NH, Dunne CP. Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections. J Hosp Infect 2022;126:29-36. [PMID: 35472487 PMCID: PMC9033628 DOI: 10.1016/j.jhin.2022.04.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2022] [Revised: 04/12/2022] [Accepted: 04/14/2022] [Indexed: 12/29/2022]

For:	Minihan B, McAuliffe E, Powell J, Wong SL, Wilkie K, Murphy C, Maher A, Power L, O'Connell NH, Dunne CP. Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections. J Hosp Infect 2022;126:29-36. [PMID: 35472487 PMCID: PMC9033628 DOI: 10.1016/j.jhin.2022.04.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2022] [Revised: 04/12/2022] [Accepted: 04/14/2022] [Indexed: 12/29/2022]

No articles found.

(The first 100,000 artilces are displayed in RCA.)